FIELD: technological processes.
SUBSTANCE: invention relates to a method for producing dicycloplatin of formula (I) . This method involves combining carboplatin with an appropriate proportion of 1,1-cyclobutane dicarboxylic acid and solvent to form a suspension, separating the precipitated solid phase from the suspension and drying the solid phase, where the solid phase contains dicycloplatin of formula (I) without the presence of a detectable amount of carboplatin. Further, the molar ratio of carboplatin and 1,1-cyclobutane dicarboxylic acid in the combining step is from about 1:1.15 to about 1:50.
EFFECT: method according to the invention is easy to use, includes mild conditions, fast reaction time, high reproducibility and allows to obtain a product that does not contain carboplatin in detectable amounts.
14 cl, 7 dwg, 10 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED PRODUCT CONTAINING DICYCLOPLATIN AND METHOD FOR ITS PRODUCTION AND USE | 2018 |
|
RU2784809C2 |
TARTRATE 3-((1R,3R)-1-(2,6-DIFLUORINE-4-((1-(3- FLUOROPROPYL)AZETIDINE-3-YL)AMINO)PHENYL)-3-METHYL-1,3,4,9-TETRAHYDRO-2H-PYRIDO[3,4-b]INDOLE-2-YL)-2,2-DIFLUOROPROPANE-1-OL, ITS SOLID FORMS, METHOD OF ITS PREPARATION AND THEIR APPLICATION | 2019 |
|
RU2809220C2 |
CRYSTALLINE FORM OF A TRICYCLIC COMPOUND AND APPLICATION THEREOF | 2019 |
|
RU2775753C1 |
CRYSTALLINE TOSYLATE SALT (8S,9R)-5-FLUORO-8-(4-FLUOROPHENYL)-9-(1-METHYL-1H-1,2,4-TRIAZOL-5-YL)-8-9-DIHYDRO-2H-PYRIDO[4,3,2-de]PHTHALAZIN-3(7H)-ONE | 2011 |
|
RU2598606C2 |
COMPOUNDS SUITABLE FOR USE AS ATR KINASE INHIBITORS | 2014 |
|
RU2687276C2 |
CRYSTALLINE SALTS AND POLYMORPHS OF P2X3 ANTAGONIST | 2017 |
|
RU2782068C2 |
METHOD OF PRODUCING ATR KINASE INHIBITORS (EMBODIMENTS) | 2014 |
|
RU2720408C2 |
3,7-DIAZABICYCLO[3,3,1]-CONTAINING PREPARATIONS AS ANTI-ARRHYTHMIC COMPOUNDS | 2002 |
|
RU2286993C2 |
SOLID FORMS OF CEFTOLOZANE | 2014 |
|
RU2703457C2 |
POLYMORPHS OF 2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE, METHODS OF PRODUCTION AND PHARMACEUTICAL USES THEREOF | 2014 |
|
RU2658009C2 |
Authors
Dates
2018-12-27—Published
2015-04-10—Filed